Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2022-003737-19Phase 2Completed
Phase 2 trial of sevoflurane and propofol (2 arms), sponsored by CHU Brugmann. Primary endpoints: Maximum force of adductor pollicis, Maximum speed of contraction of adductor pollicis and 1 more. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2022-003737-19.